Insider · CIK 0001432313
Christopher R Gordon
Files at CERE (Cerevel Therapeutics Holdings, Inc.). First filing Oct 18, 2023, latest Oct 18, 2023.
In brief
Christopher R Gordon files SEC Form 4 as director and 10% owner at CERE (Cerevel Therapeutics Holdings, Inc.). Since Oct 18, 2023, Christopher R Gordon has reported 1 open-market buy worth $125M and 0 open-market sells worth $0, the latest filed on Oct 18, 2023.
A track record needs three past buys with six months of prices behind them; Christopher R Gordon has 0, so none is measured yet.
The newest scored trade: bought $125M of CERE on Oct 16, 2023, filed Oct 18, 2023, scored 58 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 58Moderate | Cerevel Therapeutics Holdings, Inc. | $125M 5,480,052 shares | +9% | - |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 5, 2024 | CERE Cerevel Therapeutics Holdings, Inc. | AGrant or award Common Stock | +10,461 | - | - | 13,743 | Jun 7, 2024 |
| Oct 16, 2023 | CERE Cerevel Therapeutics Holdings, Inc. | POpen-market purchase Common Stockindirect: See footnotes | +5,480,052 | $22.81 | $125M | 65,679,781 | Oct 18, 2023 |
Questions about Christopher R Gordon
Answered from the filings on this page, as of the latest one.
Is Christopher R Gordon buying or selling?
Not in the last 12 months. Christopher R Gordon's latest open-market trade on SEC Form 4 was bought $125M of CERE on Oct 16, 2023.
How did Christopher R Gordon's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christopher R Gordon has 0.
Where does Christopher R Gordon file Form 4?
Christopher R Gordon has filed Form 4 at CERE (Cerevel Therapeutics Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.